LifeCycle Laboratories

LifeCycle Laboratories is developing unique diagnostics for fertility/infertility management.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location New York City, NY, USA
  • Currency USD
  • Founded July 2012
  • Employees 4
  • Website lifecyclelaboratories.com

Company Summary

LCL is developing proprietary diagnostic products based on unique discoveries of the Fragile X Mental Retardation (FMR1) gene to improve the treatment of female infertility. Our products assist women in determining their reproductive capability as well as determine IVF success rate. LCL was created to commercialize the Center for Human Reproduction's discoveries, currently being used in clinical practice today with proven outcomes.

Team

  • Valerie B. Palmieri
    President & CEO

    Ms. Palmieri is a seasoned Diagnostic executive with 30 years of experience in the diagnostics and anatomic pathology laboratory industries. She has held several senior leadership positions at DIANON Systems, Laboratory Corporation of America, DiagnoCure and most recently Principal of MOMENTUM Consulting.

  • Jill S. Steier
    Director of Finance & Business Development

    Ms. Steier is a healthcare Business Development executive with over 20 years of Investment Banking experience. Expertise primarily in public offerings, private placements, financial advisory and mergers and acquisitions with extensive transaction experience across the healthcare/life science and healthcare IT sectors. Most recently, Ms. Steier was a Managing Director with Morgan Joseph TriArtisan.

  • Norbert Gleicher
    Chairman & Founder

    Dr. Gleicher founded the Center for Human Reproduction (CHR) in 1981 and is a worldwide thought leader in the infertility field. He has held positions of Assistant Professor, Division Head of Reproductive Immunology and Director of Medical education for the Department of Ob-Gyn at Mount Sinai and was appointed Chairman of Obstetrics and Gynecology at the Mount Sinai Hospital Medical Center. He was also a Professor of Obstetrics and Gynecology a

  • David Barad
    Chief Scientific Officer

    World-renowned expert in reproductive medicine and Director of Clinical ART and Senior Scientist at The Center for Human Reproduction (CHR). He is a graduate of Rutgers Medical School and completed his residency in OB/GYN at Sloane Hospital for Women of Columbia Presbyterian Medical Center in New York. Following his residency, he did a Fellowship in Reproductive Endocrinology and Infertility at the Brigham and Women’s Hospital of Harvard Medical

Advisors

  • Richard Pinto, Esq. - Stevens & Lee/ David Dennenberg, Esq.- Davidoff, Hutcher and Citron
    Lawyer
    Unconfirmed

Previous Investors

  • Self Funded (approx. $1.0M)
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free